Newsroom

Sorted by: Latest

-

TIAA-CREF UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Teachers Insurance and Annuity Association of America/TIAA-CREF Investment Management, LLC/ Nuveen Asset Management, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...
-

Waymo, NVIDIA, Tesla and More Join A3’s Advanced Vision & AI Conference

ANN ARBOR, Mich.--(BUSINESS WIRE)--The Association for Advancing Automation (A3) today announced the speaker lineup and agenda for its Advanced Vision & AI Conference, September 23–24, 2026, in Santa Clara, California. Featuring experts from Waymo, NVIDIA, Tesla, Intrinsic, GE Vernova, Intel, FANUC, Cognex, Siemens Digital Industries, and more, the two-day conference will focus on how vision and AI technologies are being deployed across manufacturing and other industrial environments. Regis...
-

American Business Bank Announces Authorization of Third Stock Repurchase Program

LOS ANGELES--(BUSINESS WIRE)--AMERICAN BUSINESS BANK ANNOUNCES AUTHORIZATION OF THIRD STOCK REPURCHASE PROGRAM...
-

Nextpower Releases Fiscal Year 2026 Sustainability Report, Highlights SBTi Validation and 12% Reduction in Scope 3 Emissions Intensity

FREMONT, Calif.--(BUSINESS WIRE)--Nextpower™ (Nasdaq: NXT), a leading provider of clean power technology solutions, today published its fiscal year 2026 Sustainability Report, highlighting its environmental, social, and governance (ESG) progress across its operations, global supply chain, products, and expanding technology solutions platform. The company’s third annual report, and the first published under the Nextpower brand, highlights the validation of the company’s climate targets by the Sc...
-

Blykalla Expands U.S. Presence with New Technical Hub in Austin

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--Blykalla, a global leader in advanced nuclear technology, today announced a significant expansion of its U.S. presence with the opening of a new technical center in Austin, Texas. Located at 801 Barton Springs Rd, the Austin hub will house engineering and reactor development teams, strengthening Blykalla’s local operations and deepening engagement with U.S. partners, regulators, and the broader clean energy ecosystem. “We see a bright future for Blykal...
-

Older Americans Want To Travel More, But the Industry Is Leaving Them Behind, New Luggage Forward Survey Reveals 

DENVER--(BUSINESS WIRE)--Luggage Forward, an exclusive luggage delivery provider, announced findings from its survey - Older Americans aren't ready to slow down on travel....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones International Internet UCITS ETF 31.08.2026 FDNI.LN IE00BT9PVG14  425,002.00 USD   7,906,251.77   18.603  ...
-

Dr. Jay Bhaumik and Raman Bhaumik Lead Thesis Pharmacy to New Patient Safety Standard as First in Texas to Achieve CCE Accreditation

PLANO, Texas--(BUSINESS WIRE)--Thesis Pharmacy, a compounding pharmacy in Plano, Texas, that has been in business since 2018, earned accreditation from the Coalition for Compounding Excellence (CCE), becoming the first in Texas to receive this accreditation and the first in the nation to do so through CCE’s detailed safety review process. Thesis Pharmacy prepares prescriptions specifically for patients when commercially available medications do not meet their needs. Because these medications ar...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 31.08.2026 FEM IE00B8X9NX34  300,002.00 USD  15,441,659.32   51.472  ...
-

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the successful completion of the acquisition of Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases. Vertex also announced the expansion of its executive leadership team, in support of the Company’s continued growth and diversification. Completion of Acquisition of Crinetic...